Sector Gamma AS Purchases 22,943 Shares of Elevance Health, Inc. $ELV

Sector Gamma AS boosted its position in Elevance Health, Inc. (NYSE:ELV) by 238.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 32,546 shares of the company’s stock after purchasing an additional 22,943 shares during the period. Elevance Health comprises 2.6% of Sector Gamma AS’s investment portfolio, making the stock its 17th biggest position. Sector Gamma AS’s holdings in Elevance Health were worth $11,409,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Rossby Financial LCC grew its position in Elevance Health by 110.0% in the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock worth $28,000 after purchasing an additional 44 shares in the last quarter. J.Safra Asset Management Corp bought a new stake in Elevance Health in the 4th quarter worth about $32,000. ORG Partners LLC grew its position in Elevance Health by 120.4% in the 4th quarter. ORG Partners LLC now owns 108 shares of the company’s stock worth $38,000 after purchasing an additional 59 shares in the last quarter. Dorato Capital Management bought a new position in shares of Elevance Health during the 4th quarter valued at approximately $41,000. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in shares of Elevance Health during the 4th quarter valued at approximately $38,000. 89.24% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ELV has been the subject of a number of research reports. Morgan Stanley increased their target price on shares of Elevance Health from $352.00 to $404.00 and gave the company an “equal weight” rating in a research report on Thursday, June 4th. JPMorgan Chase & Co. increased their target price on shares of Elevance Health from $411.00 to $476.00 and gave the company an “overweight” rating in a research report on Monday. Robert W. Baird increased their target price on shares of Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a research report on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft raised Elevance Health from a “hold” rating to a “buy” rating and upped their price target for the company from $363.00 to $498.00 in a research report on Wednesday, May 20th. Finally, Leerink Partners set a $364.00 price target on Elevance Health in a research note on Thursday, April 23rd. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and an average price target of $416.11.

Elevance Health Stock Down 1.2%

ELV stock opened at $399.64 on Friday. The stock has a fifty day moving average of $364.53 and a 200-day moving average of $344.44. The company has a market capitalization of $86.79 billion, a price-to-earnings ratio of 17.00, a PEG ratio of 2.29 and a beta of 0.67. Elevance Health, Inc. has a fifty-two week low of $273.71 and a fifty-two week high of $426.98. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.48 and a current ratio of 1.48.

Elevance Health (NYSE:ELV) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, topping the consensus estimate of $10.74 by $1.84. The company had revenue of $49.49 billion during the quarter, compared to the consensus estimate of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. Elevance Health’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same period last year, the firm earned $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, equities research analysts predict that Elevance Health, Inc. will post 26.93 earnings per share for the current year.

Elevance Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be issued a $1.72 dividend. The ex-dividend date of this dividend is Wednesday, June 10th. This represents a $6.88 annualized dividend and a yield of 1.7%. Elevance Health’s dividend payout ratio (DPR) is 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.